Is further screening of men with baseline PSA < 1 ng ml−1worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)

Autor:	Rainer Grobholz, Luis A. Kluth, Josef Beatrice, Marco Randazzo, Felix K.-H. Chun, Franz Recker, Lukas Manka, Maciej Kwiatkowski, Stephen Wyler, Andreas Huber
Rok vydání:	2015
Předmět:	Gynecology Cancer Research medicine.medical_specialty business.industry Incidence (epidemiology) Urology Early detection urologic and male genital diseases Predictive value Number needed to screen Prostate-specific antigen Oncology Quartile Medicine business Baseline (configuration management)
Zdroj:	International Journal of Cancer. 137:553-559
ISSN:	0020-7136
DOI:	10.1002/ijc.29420
Popis:	Recent studies indicate frequent early PSA retesting unrelated of men's baseline PSA, which increases the harms of early detection especially among men with low PSA. The current study investigates the PCa incidence among men with baseline PSA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4f55a1db491d233e4299721232827c5 https://doi.org/10.1002/ijc.29420 Zobrazit plný text záznamu Plný text